The board of directors of Alibaba Health Information Technology Limited announced the appointment of a new chief executive officer, executive Director, chairman of the Board and authorized representative of the Company under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, Mr. Zhu Shunyan, with effect from March 16, 2020. Mr. Zhu, aged 49, is the President of the Innovation Initiatives Segment of the ultimate controlling shareholder of the Company, Alibaba Group Holding Limited (which American depositary shares, each representing eight ordinary shares, are listed on the New York Stock Exchange, and which ordinary shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited and its subsidiaries. Prior to joining Alibaba Group, Mr. Zhu founded Wuhan Xuncai Technology Co.

Ltd. in 2003. The Board announced that Mr. Shen Difan has tendered his resignation as the chief executive officer of the Company, and will cease to act as one of the authorized representatives of the Company under the Listing Rules, with effect from March 16, 2020. Mr. Shen will hand over his responsibilities at the Company to re-join Alibaba Group.

The Board further announced that Mr. Wu Yongming has tendered his resignation as the chairman of the Board and the chairman of the nomination committee of the Company, all with effect from March 16, 2020, but will continue to serve as a non-executive director and a member of the remuneration committee on the Board. Mr. Wu will step down as the chairman of the Board and the chairman of the Nomination Committee, to better focus on his other business engagements. Then Board further announced that Mr. Zhu has been appointed as the chairman of the Nomination Committee with effect from March 16, 2020.